Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.

Autor:	Joosten, S. C.1,2 (AUTHOR), Odeh, S. N. O.1 (AUTHOR), Koch, A.1 (AUTHOR), Buekers, N.1 (AUTHOR), Aarts, M. J. B.2 (AUTHOR), Baldewijns, M. M. L. L.3 (AUTHOR), Van Neste, L.1 (AUTHOR), van Kuijk, S.4 (AUTHOR), Schouten, L. J.5 (AUTHOR), van den Brandt, P. A.5 (AUTHOR), Tjan-Heijnen, V. C.2 (AUTHOR), van Engeland, M.1 (AUTHOR), Smits, K. M.1 (AUTHOR) kim.smits@maastrichtuniversity.nl
Zdroj:	Clinical Epigenetics. 5/4/2021, Vol. 13 Issue 1, p1-11. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu